Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States
Gregory S Hoeker
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States
Anita Alvarez-Laviada
Department of Myocardial Function, Imperial College London, London, United Kingdom
Daniel Hoagland
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States
Xiaoping Wan
Heart and Vascular Research Center, MetroHealth Medical Center, Department of Medicine, Case Western Reserve University, Cleveland, United States
D Ryan King
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States; Graduate Program in Translational Biology, Medicine and Health, Virginia Tech, Virginia, United States
Jose Sanchez-Alonso
Department of Myocardial Function, Imperial College London, London, United Kingdom
Chunling Chen
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, United States
Jane Jourdan
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States
Lori L Isom
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, United States
Isabelle Deschenes
Heart and Vascular Research Center, MetroHealth Medical Center, Department of Medicine, Case Western Reserve University, Cleveland, United States; Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Unites States
James W Smyth
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States; Department of Biological Sciences, College of Science, Blacksburg, United States
Julia Gorelik
Department of Myocardial Function, Imperial College London, London, United Kingdom
Steven Poelzing
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States; Department of Biomedical Engineering and Mechanics, Virginia Polytechnic University, Blacksburg, United States
Virginia Tech Carilion Research Institute, Virginia Polytechnic University, Roanoke, United States; School of Medicine, Virginia Polytechnic University, Roanoke, United States; Department of Biomedical Engineering and Mechanics, Virginia Polytechnic University, Blacksburg, United States
Computational modeling indicates that cardiac conduction may involve ephaptic coupling – intercellular communication involving electrochemical signaling across narrow extracellular clefts between cardiomyocytes. We hypothesized that β1(SCN1B) –mediated adhesion scaffolds trans-activating NaV1.5 (SCN5A) channels within narrow (<30 nm) perinexal clefts adjacent to gap junctions (GJs), facilitating ephaptic coupling. Super-resolution imaging indicated preferential β1 localization at the perinexus, where it co-locates with NaV1.5. Smart patch clamp (SPC) indicated greater sodium current density (INa) at perinexi, relative to non-junctional sites. A novel, rationally designed peptide, βadp1, potently and selectively inhibited β1-mediated adhesion, in electric cell-substrate impedance sensing studies. βadp1 significantly widened perinexi in guinea pig ventricles, and selectively reduced perinexal INa, but not whole cell INa, in myocyte monolayers. In optical mapping studies, βadp1 precipitated arrhythmogenic conduction slowing. In summary, β1-mediated adhesion at the perinexus facilitates action potential propagation between cardiomyocytes, and may represent a novel target for anti-arrhythmic therapies.